Ticker
ACRSCompany Name
ACLARIS THERAPEUTICS INCSector
HealthcareIndustry
Diagnostics & ResearchExchange
NASDAQDate | Free Cash Flow | Free Cash Flow per Share | Share Factor | Weighted Average Shares |
---|---|---|---|---|
6/30/2025 | $ -10.05M | $ -0.08 | 1 | 122.58M |
3/31/2025 | $ -12.35M | $ -0.1 | 1 | 122.39M |
12/31/2024 | $ -20.2M | $ -0.26 | 1 | 77.3M |
9/30/2024 | $ -18.46M | $ -0.26 | 1 | 71.38M |
6/30/2024 | $ -65.1M | $ -0.91 | 1 | 71.29M |
3/31/2024 | $ -73.68M | $ -1.04 | 1 | 71.07M |
12/31/2023 | $ -79.63M | $ -1.14 | 1 | 69.81M |
9/30/2023 | $ -91.65M | $ -1.29 | 1 | 70.81M |
6/30/2023 | $ -74.98M | $ -1.06 | 1 | 70.63M |
3/31/2023 | $ -73.94M | $ -1.11 | 1 | 66.87M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCF / (Shares WA * Share Factor)
(=) FCFPS
FCFPS for ACLARIS THERAPEUTICS INC is calculated as follows: FCF [ $ -50.88M ] / (Shares WA [ 42.8M ] * Share Factor [ 1 ])
(=) FCFPS [ $ -1.19 ]
Minimum
Sep 30, 2023
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 3.76K |
---|---|
min | $ -7.96 |
max | $ 8.85 |
average | $ 0.8 |
median | $ 0.29 |
std | $ 2.82 |